Secondly, we did not examine bone morphometric parameters in middle-aged or elderly mice, which may be more clinically relevant for osteoporosis studies, although sclerostin inhibition is also being investigated for use in children with rare bone diseases such as osteogenesis imperfecta. Here, SOST is linked to osteoporosis.